'Pfizer said it would begin offloading its 32 per cent stake in consumer health business Haleon as it focuses on reducing debt linked to its $43bn acquisition of Seagen and boosting returns to shareholders.'

https://www.ft.com/content/ec441144-52ae-4fa2-8a04-4238db0ee504